๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Intraoperative management of liver transplant patients with pulmonary hypertension

โœ Scribed by Csete, M


Publisher
Wiley (John Wiley & Sons)
Year
1997
Tongue
English
Weight
52 KB
Volume
3
Category
Article
ISSN
1074-3022

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Clinical predictors of pulmonary hyperte
โœ Nektarios D. Pilatis; Larry E. Jacobs; Pairoj Rerkpattanapipat; Morris N. Kotler ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 68 KB

Clinical prediction of portopulmonary hypertension (PPHTN) is critical in the preoperative evaluation of candidates for orthotopic liver transplantation (OLT) because of its association with significant morbidity and mortality. To determine the clinical, laboratory, and echocardiographic predictors

Endoscopic management of the liver trans
โœ Jose G. de la Mora-Levy; Todd H. Baron ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 395 KB ๐Ÿ‘ 1 views

E ndoscopy is useful for the evaluation of liver trans- plant (LT) patients during the pretransplantation and posttransplantation period (Table 1). Prior to transplantation, endoscopy is most commonly used for prevention and/or management of gastrointestinal bleeding from portal hypertension. Posttr

Pulmonary hypertension after liver trans
โœ David G. Koch; Michael Caplan; Adrian Reuben ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 315 KB ๐Ÿ‘ 1 views

Hepatopulmonary syndrome and portopulmonary hypertension are the most common pulmonary vascular complications in patients with cirrhosis. Usually but not universally mutually exclusive, they each may present prior to liver transplantation and, if severe enough, may be a contraindication to transplan

Sildenafil therapy is associated with im
โœ Michael S. Gough; R. James White ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 165 KB

Pulmonary arterial hypertension associated with portal hypertension occurs in about 5% of patients being evaluated for liver transplantation. Treatment is required to facilitate safe transplantation, and oral pulmonary vasodilators have yet to be prospectively evaluated for this disease. The objecti